期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

105例乳腺癌肺转移患者的相关危险因素和预后分析 被引量：2

暂未订购
导出
摘要 目的探讨乳腺癌肺转移患者的相关危险因素和预后分析。方法回顾性分析我院2007年4月至2012年1月确诊为乳腺癌合并肺转移患者105例的临床资料,COX回归单因素分析与乳腺癌患者肺部转移的相关危险因素。结果乳腺癌肺转移与患者性别、肿瘤大小、分化程度等无关,而与腋窝淋巴结转移、激素受体状态、Cerb-B-2状态及无转移期有关(P<0.05)。结论肺转移是乳腺癌患者首发转移部位,淋巴结转移、Cerb-B-2阳性而激素受体阴性等是发生肺转移的危险因素,应加强对此类患者的综合治疗管理。
作者 揭超
机构地区 广东医学院附属廉江医院
出处 《中国实用医药》 2013年第13期145-146,共2页 China Practical Medicine
关键词 乳腺癌 肺转移 危险因素
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献7

  • 1LEE Y T. Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol, 1983, 23(3) :175-180.
  • 2BESLIJAS, BONNETERREJ, BURSTEINH. Third consensus on medical treatment of metastatic breast cancer. Ann Oncol, 2009,20 (11) :177-178.
  • 3DIAZ-CANTON E A, VALERO V, RAHMAN Z, et al. Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy. The University of Texas M.D. Anderson Cancer Center experience and review ofthe literature. Ann Oncol, 1998, 9(4) :413-418.
  • 4肖伟,孙明智,陈国林.乳腺癌术后肺转移65例临床分析[J].中国城乡企业卫生,2008,23(4):44-45. 被引量：2
  • 5CHEN F, FUJINAGA T, SATO K, et al. Clinical features of surgi- cal resection for pulmonary metastasis from breast cancer. Eur J Surg Onco1,2009, 35 (4) : 393-397.
  • 6邱梅清,佟仲生,郝春芳,贾勇圣,刘晓东.乳腺癌肺转移117例临床病理特征及预后相关因素分析[J].肿瘤,2012,32(11):907-912. 被引量：13
  • 7GAO D, DU J, CONG L, et al. Risk factors for initial lung metas- tases from breast invasive ductal carcinoma in stages I -111 of oper- able patients. Jpn J Clin Oncol, 2009, 39(2) :97-104.

二级参考文献22

  • 1BESLIJA S, BONNETERRE J, BURSTEIN H. Third consensus on medical treatment of metastatic breast cancer[J]. Ann Oncol, 2009, 20(11 ):1771-1785.
  • 2DIAZ-CANTON E A, VALERO V, RAHMAN Z, et al. Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy. The University of Texas M.D. Anderson Cancer Center experience and review of the literature[J]. Ann Oncol, 1998, 9(4):413-41 8.
  • 3LEE Y T. Breast carcinoma: pattern of metastasis at autopsy[J].J Surg Oncol, 1983, 23(3):1 75-180.
  • 4TAMIMI R M, COLDITZ G A, HAZRA A, et al. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer[J]. Breast Cancer Res Treat, 1 31 (1): 1 5 9-1 6 7.
  • 5EARLY BREAST CANCER TRIALISTS'COLLABORATIVE GROUP (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials [J]. Lancet, 2005, 365(9472): 1687-1717.
  • 6INGLE J N. Principles of treatment in advanced breast cancer[J]. HematolOncol Clin North Am, 1 989, 3(4):743-763.
  • 7ALTUNDAG K, BONDY M L, MIRZA N Q, et al. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis[J]. Cancer, 2007, 110(12):2640-2647.
  • 8PENTHEROUDAKIS G, FOUNTZILAS G, BAFALOUKOS D, et al. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women[J]. Breast Cancer Res Treat, 2006, 97(3):237-244.
  • 9DUAN X F, DONG N N, ZHANG T, et al. The prognostic analysis of clinical breast cancer subtypes among patients with liver metastases from breast cancer[J]. IntJ Clin Oncol, 2011 Oct 27. [Epub ahead of print].
  • 10SWENERTON K D, LEGHA S S, SMITH T, et al. Prognostic factors in metastatic breast cancer treated with combination chemotherapy[J]. Cancer Res, 1979, 39(5):1552-1562.

共引文献13

同被引文献10

引证文献2

二级引证文献29

中国实用医药
2013年 第13期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部